Publications by authors named "Jeff S Isenberg"

Claim this Profile
T
Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.
David R Soto-Pantoja, Jeff S Isenberg, David D Roberts

J Genet Syndr Gene Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.
Elfaridah P Frazier, Jeff S Isenberg, Sruti Shiva, Lei Zhao, Paul Schlesinger

Matrix Biol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
Mingyi Yao, David D Roberts, Jeff S Isenberg

Pharmacol Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
Eileen M Bauer, Yan Qin, Thomas W Miller, Russell W Bandle, Gabor Csanyi, Jeff S Isenberg

Cardiovasc Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
Sukhbir Kaur, Gema Martin-Manso, Michael L Pendrak, Susan H Garfield, Jeff S Isenberg

J Biol Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
Thomas W Miller, Jeff S Isenberg, Hubert B Shih, Yichen Wang, David D Roberts

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
Thomas W Miller, Jeff S Isenberg, David D Roberts

Br J Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton.
Yifeng Jia, Shiaw-Lin Wu, Jeff S Isenberg, Shujia Dai, John M Sipes

Cell Stress Chaperones· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling.
Justin B Maxhimer, David R Soto-Pantoja, Lisa A Ridnour, Hubert B Shih, William G Degraff, Jeff S Isenberg

Sci Transl Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Jeff S Isenberg, Sruti Shiva, Mark Gladwin

Nitric Oxide· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
Thomas W Miller, Jeff S Isenberg, David D Roberts

Chem Rev· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.
Jeff S Isenberg, Gema Martin-Manso, Justin B Maxhimer, David D Roberts

Nat Rev Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.
Jeff S Isenberg, Yan Qin, Justin B Maxhimer, John M Sipes, Daryl Despres

Matrix Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Jeff S Isenberg, Douglas S Annis, Michael L Pendrak, Malgorzata Ptaszynska, William A Frazier

J Biol Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling.
Jeff S Isenberg, Justin B Maxhimer, Perlita Powers, Maria Tsokos, William A Frazier

Surgery· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin.
Shujia Dai, Yifeng Jia, Shiaw-Lin Wu, Jeff S Isenberg, Lisa A Ridnour

J Proteome Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
Jeff S Isenberg, Justin B Maxhimer, Fuminori Hyodo, Michael L Pendrak, Lisa A Ridnour

Am J Pathol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
Jeff S Isenberg, William A Frazier, Murali C Krishna, David A Wink, David D Roberts

Curr Drug Targets· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.
Jeff S Isenberg, Fuminori Hyodo, Lisa A Ridnour, Caitlin S Shannon, David A Wink

Neoplasia· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
Jeff S Isenberg, Martin J Romeo, Justin B Maxhimer, Jeremy Smedley, William A Frazier

Ann Surg· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47: a new target in cardiovascular therapy.
Jeff S Isenberg, David D Roberts, William A Frazier

Arterioscler Thromb Vasc Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells.
Jeff S Isenberg, Christine Yu, David D Roberts

Biochem Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.
Jeff S Isenberg, Martin J Romeo, Christine Yu, Christine K Yu, Khauh Nghiem

Blood· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
Jeff S Isenberg, Loretta K Pappan, Martin J Romeo, Mones Abu-Asab, Maria Tsokos

Ann Surg· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
Jeff S Isenberg, Fuminori Hyodo, Loretta K Pappan, Mones Abu-Asab, Maria Tsokos

Arterioscler Thromb Vasc Biol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis